Alector Inc
Change company Symbol lookup
Select an option...
ALEC Alector Inc
ARCC Ares Capital Corp
GME GameStop Corp
FTDR Frontdoor Inc
HD Home Depot Inc
SRCE 1st Source Corp
PNC PNC Financial Services Group Inc
AAPL Apple Inc
MSFT Microsoft Corp
FAZE FaZe Holdings Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegenerative diseases. The Company is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. Its clinical programs include AL001 (latozinemab), AL101, and AL002. In addition, the Company also focuses on preclinical and research programs in its pipeline for indications, including Alzheimer’s disease, Parkinson’s disease, and oncology. Its first product candidate, latozinemab, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients.

Price
Delayed
$6.13
Day's Change
-0.355 (-5.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.46
Day's Low
6.10
Volume
(Light)

Today's volume of 261,709 shares is on pace to be much lighter than ALEC's 10-day average volume of 994,943 shares.

261,709
  • Prev Close
    6.48
  • Today's Open
    6.46
  • Day's Range
    6.10-6.46
  • Avg Vol (10-day)
    994.9K
  • Last (time)
    2:57p ET 10/02/23
  • Last (size)
    100
  • 52-Wk Range
    4.98 - 9.86
    LowHigh
  • (09/30/22 - 09/05/23)
    22.99%
  • 73.4%
  • Market Cap
    513.5M
  • Shares Outstanding
    83.8M
  • -1.68
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 82.99
  • (% of float 09/15/23)
    8.17

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.